540694 — ANG Lifesciences India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹430.92m
- IN₹1.15bn
- IN₹928.93m
Annual cashflow statement for ANG Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 535 | 26.3 | -107 | -157 | -130 |
| Depreciation | |||||
| Non-Cash Items | 109 | 113 | 115 | 71.8 | 92.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -456 | 30.6 | -187 | 19.9 | 85 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 247 | 264 | -94.9 | -2.55 | 110 |
| Capital Expenditures | -413 | -104 | -55.7 | -37.5 | -4.39 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -30.7 | 11.2 | 255 | 21.6 | 14.9 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -444 | -93.3 | 199 | -15.9 | 10.5 |
| Financing Cash Flow Items | -79.6 | -117 | -106 | -83.8 | -77.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 199 | -171 | -104 | 16.8 | -117 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.35 | -0.218 | -0.057 | -1.61 | 3.37 |